Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.55 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.44 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | LARS1 | Q9P2J5 | 1/20 | 0.43 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | MME | P08473 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | LAP3 | P28838 | 2/20 | 0.39 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.39 |
| ▸ | PLA2G5 | P39877 | 1/20 | 0.39 |
| ▸ | CTSD | P07339 | 1/20 | 0.39 |
| ▸ | BACE1 | P56817 | 1/20 | 0.39 |
| ▸ | SCN9A | Q15858 | 3/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | ANPEP | P15144 | 2/20 | 0.39 |
| ▸ | RNPEP | Q9H4A4 | 2/20 | 0.39 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3057410 | 1.00 | SLC7A5 (0.55) | SLC7A5SLC1A3SLC1A2SMN1; SMN2LARS1 | |
| SCHEMBL9359613 | 1.00 | SLC7A5 (0.55) | SLC7A5SLC1A3SLC1A2SMN1; SMN2LARS1 | |
| SCHEMBL31345674 | 1.00 | SLC7A5 (0.55) | SLC7A5SLC1A3SLC1A2SMN1; SMN2LARS1 | |
| SCHEMBL8651654 | 1.00 | SLC7A5 (0.55) | SLC7A5SLC1A3SLC1A2SMN1; SMN2LARS1 | |
| Hydrochloric Acid SCHEMBL17438473 | 0.98 | SLC7A5 (0.53) | SLC7A5SLC1A3SLC1A2SMN1; SMN2LARS1 | |
| D-Leucine SCHEMBL8650098 | 0.96 | SLC7A5 (0.62) | SLC7A5SLC1A3SLC1A2SMN1; SMN2LARS1 | |
| SCHEMBL29349635 | 0.96 | SLC7A5 (0.52) | SLC7A5SLC1A3SLC1A2SMN1; SMN2LARS1 | |
| SCHEMBL9359920 | 0.93 | SLC7A5 (0.48) | SLC7A5SLC1A3SLC1A2SMN1; SMN2LARS1 | |
| SCHEMBL31265327 | 0.93 | SLC7A5 (0.48) | SLC7A5SLC1A3SLC1A2SMN1; SMN2LARS1 | |
| SCHEMBL3066882 | 0.92 | SLC7A5 (0.47) | SLC7A5ALDH1A1MAPTLAP3CTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 184 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026087804-A1 | METHOD FOR PRODUCING SELF-ASSEMBLING DIPEPTIDES | FERTINAGRO BIOTECH, S.L. (ES) | 2026-04-30 | — | — | WO | claimed |
| EP-4659591-A1 | TASTE-ENHANCING COMPOSITION, METHOD FOR PRODUCING SAME, FOOD PRODUCT, AND METHOD FOR ENHANCING TASTE OF FOOD PRODUCT | House Foods Group Inc. (JP) | 2025-12-10 | — | — | EP | claimed |
| US-20250205310-A1 | METHOD FOR REVERSING BODY-WIDE AGE-ASSOCIATED FUNCTIONAL CHANGES | THE CHINESE UNIVERSITY OF HONG KONG (CN) | 2025-06-26 | — | — | US | claimed |
| CN-119007832-B | Blood metabolism marker set for Alzheimer disease diagnosis and screening method and application thereof | 复旦大学 | 2025-04-04 | — | — | CN | claimed |
| US-12162959-B2 | Cyclic peptide for treating cancer | SAINT LEO UNIVERSITY (US) | 2024-12-10 | — | — | US | claimed |
| WO-2024162422-A1 | TASTE-ENHANCING COMPOSITION, METHOD FOR PRODUCING SAME, FOOD PRODUCT, AND METHOD FOR ENHANCING TASTE OF FOOD PRODUCT | ハウス食品グループ本社株式会社 | 2024-08-08 | — | — | WO | claimed |
| CN-118221777-A | Polypeptide for repairing skin wound or mucous membrane injury and application thereof | 四川好医生攀西药业有限责任公司 | 2024-06-21 | — | — | CN | claimed |
| CN-117789993-B | Establishment and application of gastric cancer prediction model based on tongue fur metabolite | 浙江省肿瘤医院 | 2024-06-11 | — | — | CN | claimed |
| CN-117789993-A | Establishment and application of gastric cancer prediction model based on tongue fur metabolite | 浙江省肿瘤医院 | 2024-03-29 | — | — | CN | claimed |
| US-20230410977-A1 | METHODS AND MATERIALS FOR ASSESSING RADIATION EXPOSURE | NUTECH VENTURES | 2023-12-21 | — | — | US | claimed |
| US-20230295233-A1 | POLYPEPTIDE FOR REPAIRING MUCOSAL DAMAGE OR SKIN WOUND AND USE THEREOF | SICHUAN GOODDOCTOR PANXI PHARMACEUTICAL CO., LTD. (CN) | 2023-09-21 | — | — | US | claimed |
| CN-115047120-B | Method for analyzing and detecting dansyl chloride derivative of dipeptide substances in white spirit Daqu | 贵州茅台酒股份有限公司 | 2023-08-29 | — | — | CN | claimed |
| CN-116133673-A | Polypeptide for repairing mucous membrane injury or skin wound and application thereof | 四川好医生攀西药业有限责任公司 | 2023-05-16 | — | — | CN | claimed |
| EP-4177259-A1 | POLYPEPTIDE FOR REPAIRING MUCOSAL DAMAGE OR SKIN WOUND AND USE THEREOF | Sichuan Gooddoctor Panxi Pharmaceutical Co. Ltd (CN) | 2023-05-10 | — | — | EP | claimed |
| CN-115397460-A | Methods of making cells expressing chimeric antigen receptors | 诺华股份有限公司 | 2022-11-25 | — | — | CN | claimed |
| CN-115047120-A | Dansyl chloride derivatization method for analyzing and detecting dipeptide substances in white spirit Daqu | 贵州茅台酒股份有限公司 | 2022-09-13 | — | — | CN | claimed |
| WO-2022148418-A1 | PHARMACEUTICAL COMPOSITION CAPABLE OF BEING DELIVERED BY METERED DOSE INHALER | 江苏恒瑞医药股份有限公司 | 2022-07-14 | — | — | WO | claimed |
| WO-2022140565-A1 | METHODS AND MATERIALS FOR ASSESSING RADIATION EXPOSURE | NUTECH VENTURES (US) | 2022-06-30 | — | — | WO | claimed |
| CN-112812149-B | Amino acid derivative, preparation method and application thereof, anti-tumor micelle and preparation method thereof | 首都医科大学 | 2022-04-29 | — | — | CN | claimed |
| US-20160016929-A1 | PRO-DRUG COMPOUNDS | PROXIMAGEN LIMITED | 2016-01-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160016929-A1 | PRO-DRUG COMPOUNDS | H1-0, ZYX, FURIN | SLC7A5 723/4885SLC1A3 1278/4885SLC1A2 2146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.